Speed, Scale, and Success: Why Rapid Bispecific Antibody Development Matters The Need for Speed in Drug Development With bispecific antibody innovation accelerating, speed has become a critical ...

A new dataset for predicting antigen-antibody interactions, published in the prestigious machine learning conference NeurIPS 2023, will help accelerate AI drug discovery KYOTO, Japan--(BUSINESS ...

Mathieu Bennet: In B-cell cloning, single-cell isolation occurs at two crucial stages. First, during the initial screening ...

Those tweaks may improve one property—how easily the antibody can be made at scale, for instance—but have a disastrous effect on the many other attributes required, such as selectivity ...

STUTTGART, Germany I June 27, 2025 I La Merie Publishing announced the release of its newest technology market report about gene therapy technologies for in vivo expression of antibodies. The report ...

“We do not test different scale-up strategies for our projects, as our scale-up strategy is not influenced by the specific product being expressed. Whether the product is a standard IgG1 ...

The development of their production processes is still challenging because of regulatory requirements and complex and sophisticated process strategies. Development and scale-up of cell culture ...

Archon Bioscience s, a biotech startup putting AI to work designing novel biomolecules, has just emerged from stealth with an impressive $20 million in seed funding.The company aims to supercharge ...

The work, published today as a Reviewed Preprint in eLife, uses a high-throughput sequencing-based assay to quantify antibody immunity against circulating H3N2 flu strains in both children and adults.

Autoimmune hepatitis (AIH) is a severe autoimmune disease characterized by immune-mediated hepatocyte destruction, leading to hepatic necroinflammation, cirrhosis, and potential fatality. N6 ...